Pfizer, Inc. (PFE): Perhaps a study on a combination of Vasc...

Followed By	58
Posts	6467
Boards Moderated	1
Alias Born	01/02/2003

ziploc_1

Sunday, May 01, 2022 7:49:37 AM

Re: DewDiligence post# 4843

Perhaps a study on a combination of Vascepa and Paxlovid could achieve statistical significance in preventing Covid infections in patients who were in contact with people already infected with Covid.

Recent PFE News

Pfizer Announces Submission of New Drug Application to the U.S. FDA for PAXLOVID™ • Business Wire • 06/30/2022 10:45:00 AM
Pfizer (PFE) Receives a Hold from SVB Securities • TipRanks • 06/30/2022 04:55:57 AM
Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine • Business Wire • 06/29/2022 08:45:00 PM
Pfizer Stock: Plenty Left in the Vial Despite COVID-19 Waning • TipRanks • 06/29/2022 05:41:35 AM
Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus • Business Wire • 06/28/2022 10:00:00 AM
Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus • GlobeNewswire Inc. • 06/28/2022 10:00:00 AM
Pfizer (PFE) Gets a Hold Rating from Barclays • TipRanks • 06/27/2022 12:55:26 PM
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron • Business Wire • 06/25/2022 02:00:00 PM
Pfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Analysts • Business Wire • 06/24/2022 02:00:00 PM
Pfizer Declares Third-Quarter 2022 Dividend • Business Wire • 06/23/2022 02:35:00 PM
Enanta: Filed Patent Infringement Suit Against Pfizer Over Paxlovid • Dow Jones News • 06/21/2022 09:47:00 PM
Valneva Shares Jump 85% After Pfizer Investment • Dow Jones News • 06/21/2022 02:51:00 PM
Valneva Shares Keep Rising After Pfizer Deal • Dow Jones News • 06/21/2022 09:46:00 AM
Valneva Shares Climb as Pfizer Takes $95 Million Stake • Dow Jones News • 06/20/2022 08:07:00 AM
Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15 • Business Wire • 06/20/2022 05:00:00 AM
Pfizer, BioNTech to Begin Shipping Covid-19 Vaccines for Children • Dow Jones News • 06/17/2022 02:33:00 PM
Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children 6 Months through 4 Years of Age • Business Wire • 06/17/2022 01:24:00 PM
Myovant Sciences and Pfizer Announce Publication in The Lancet of Phase 3 SPIRIT 1 and SPIRIT 2 Studies of Once-Daily Relugolix Combination Therapy in Women With Endometriosis-Associated Pain • GlobeNewswire Inc. • 06/17/2022 10:45:00 AM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/16/2022 06:07:49 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/16/2022 06:07:48 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/16/2022 06:07:43 PM
Akero Gets Investment From Pfizer as Part of Efruxifermin Funding • Dow Jones News • 06/16/2022 12:02:00 PM
Akero Therapeutics Announces Two Financing Transactions with Pfizer Inc. and Hercules Capital, Inc. Providing Access to Up To $125 Million • GlobeNewswire Inc. • 06/16/2022 11:00:00 AM
Pfizer Gives Additional Data on Paxlovid, Ceasing Enrollment in EPIC-SR Study • Dow Jones News • 06/14/2022 09:42:00 PM
Pfizer Reports Additional Data on PAXLOVID™ Supporting Upcoming New Drug Application Submission to U.S. FDA • Business Wire • 06/14/2022 08:30:00 PM

More PFE News

InvestorsHub NewsWire

Maison Luxe Reports Best Ever Annual Revenues of Approximately $ 17.6 mil. for 2022 as Compared to Approximately $ 5.2 mil. for 2021, an Increase of Over 300% and Poised for Rapid Expansion in 2023 • MASN • Jun 30, 2022 9:58 AM

Global Fiber Technologies Secures Second Round of Inventory Financing • GFTX • Jun 30, 2022 9:41 AM

Sugarmade Announces Fully Executed LOI Toward Minority Stake Acquisition of Turnkey Cannabis Cultivation Property • SGMD • Jun 30, 2022 8:30 AM

HPIL(HPIL) Updates Shareholders • HPIL • Jun 30, 2022 8:30 AM

Emerging Markets Report: Cheaper. Simpler. More efficient. Ready to scale. • SPYR • Jun 29, 2022 11:41 AM

Oncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System • ONPH • Jun 29, 2022 9:23 AM

Infobird Co., Ltd Provides Digital and Intelligent Customer Engagement Solution to Enhance Patient Vaccination Notification Services for a Top-10 Global Pharmaceutical Company's Subsidiary • IFBD • Jun 29, 2022 8:34 AM

Goldshore Resources Drills 78.35m at 1.17 g/t Au and delineates higher grade lenses within Moss lake Deposit • GSHRF • Jun 29, 2022 8:33 AM

PSYC Provides Encouraging Update on its Investment in The Conscious Fund • PSYC • Jun 29, 2022 8:30 AM

Health Advance Inc. (OTC: HADV): Embrace their CBD Innovation Before Everyone Else Does! • HADV • Jun 29, 2022 8:00 AM

Resgreen Group Announces LilBuddy ™ Pilot Testing of Payload Capacity Exceeding Original Expectations • RGGI • Jun 29, 2022 6:00 AM

IGEN's CEO provides mid-year progress update for 2022 • IGEN • Jun 29, 2022 6:00 AM

Splash Beverage Group to Distribute TapouT through Save-A-Lot Grocery Stores in 32 States. • SBEV • Jun 28, 2022 8:23 AM

RYU Apparel Inc. (TSXV: RYU) (OTCQB: RYPPF) Announces Company Achievements and Roadmap For Shareholders with growth in Operations, Rollup Acquisition Strategy, and Disruptive Technology Opportunities • RYPPF • Jun 27, 2022 11:48 AM

Dalrada Energy Services Announces Partnership with Banyan Infrastructure to Improve ESG Banking Transparency • DFCO • Jun 27, 2022 9:35 AM

Start posting your company's news
Only $200 per official company press release!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Quotes:

IHub:

More PFE News

Detailed Quote